Literature DB >> 5359961

Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

D Alarcón-Segovia, E Fishbein, V M Betancourt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5359961      PMCID： PMC1579124     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  21 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  LUPUS DIATHESIS AND THE HYDRALAZINE SYNDROME.

Authors:  D ALARCON SEGOVIA; J W WORTHINGTON; L E WARD; K G WAKIM
Journal:  N Engl J Med       Date:  1965-03-04       Impact factor: 91.245

3.  Systemic lupus erythematosus: a complex auto-immune disorder.

Authors:  W DAMESHEK
Journal:  Ann Intern Med       Date:  1958-04       Impact factor: 25.391

4.  [Lupoid syndromes after absorption of isoniazid. Study of 6 cases].

Authors:  N Debeyre; M F Kahn; S de Sèze
Journal:  Sem Hop       Date:  1967-11-26

5.  A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism.

Authors:  E J Lappat; M J Cawein
Journal:  Am J Med       Date:  1968-12       Impact factor: 4.965

6.  The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies.

Authors:  P G Frost; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

7.  Natural antibodies to procaine amide.

Authors:  A S Russell; M Ziff
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

8.  Activation of systemic lupus erythematosus by drugs.

Authors:  S L Lee; I Rivero; M Siegel
Journal:  Arch Intern Med       Date:  1966-05

9.  The epidemiology of drug-induced systemic lupus erythematosus.

Authors:  M Siegel; S L Lee; N S Peress
Journal:  Arthritis Rheum       Date:  1967-10

10.  METHODS FOR THE PURIFICATION OF THYMUS NUCLEI AND THEIR APPLICATION TO STUDIES OF NUCLEAR PROTEIN SYNTHESIS.

Authors:  V G ALLFREY; V C LITTAU; A E MIRSKY
Journal:  J Cell Biol       Date:  1964-05       Impact factor: 10.539
View more
  8 in total

1.  Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).

Authors:  J H ten Veen; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

2.  Antigenic specificity of chlorpromazine-induced antinuclear antibodies.

Authors:  D Alarcón-Segovia; E Fishbein; J A Cetina; R J Raya; E Barrera
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

4.  Strain difference in the immune response to hydralazine in inbred guinea-pigs.

Authors:  L Ellman; J Inman; I Green
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

5.  Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.

Authors:  A Klajman; N Camin-Belsky; A Kimchi; S Ben-Efraim
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

6.  Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract.

Authors:  T Ghose; J H Quigley; P L Landrigan; A Asif
Journal:  Br J Ophthalmol       Date:  1973-12       Impact factor: 4.638

7.  Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide.

Authors:  Y Shoenfeld; Y Vilner; T Reshef; A Klajman; A Skibin; O Kooperman; R C Kennedy
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

Review 8.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.